Navigation Links
OmegaGenesis Unveils Novel Nanotechnology Platform With Broad Biomedical Applications
Date:12/15/2008

New Company Founded on Mayo Clinic Discoveries is Developing Therapies for Wounds, Diabetic Foot Ulcers and Hair Growth Using Nano-Materials with Angiogenic Properties

GILROY, Calif., Dec. 15 /PRNewswire/ -- OmegaGenesis today unveiled the company's novel technology platform which employs nano-materials made of rare earth elements with angiogenic properties. Nanorod therapies for wound healing, diabetic foot ulcers and hair growth are being developed by the company, with plans to expand into the therapeutic areas of ischemic heart damage and orthopedics in the future.

OmegaGenesis has developed novel methods to safely generate large-scale quantities of the nano-scale europium hydroxide rods, which were first developed at the Mayo Clinic and shown to promote angiogenesis, the formation of new blood vessels. The company has established non-toxicity of the europium hydroxide nanorods in lab testing for human applications and pre-clinical studies for use of the nanorods in the treatment of wound healing, diabetic foot ulcers and hair growth are underway. Clinical trials are anticipated to commence in the second half of 2009.

"The angiogenic properties of the europium hydroxide nanorods open up a diverse set of biomedical applications and treatment classes that OmegaGenesis is pursuing," said Oostur Raza, CEO and co-founder. "We are excited to be using nano-scale materials for applications in medicine as it offers a number of advantages over conventional therapies. Nano-materials will enable doctors to treat disease at a sub-cellular level in a less invasive manner than treating disease at the organ or systemic level."

While OmegaGenesis is initially focusing its efforts on developing therapies based on angiogenesis, the company plans to eventually pursue applications in diagnostics and medical imaging, as well as anti-angiogenic therapies for inhibition of tumor growth in cancer.<
'/>"/>

SOURCE OmegaGenesis
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Schering-Plough Unveils Top-Line Study Results for SAPHRIS(TM) (asenapine) Demonstrating Efficacy in Long-Term Schizophrenia Relapse Prevention
2. NeoVista Unveils 18-month Data on Novel Wet AMD Therapy at Retina Society Meeting
3. Oregon Tourism Commission Unveils New Online Customer Service Training Program
4. Portola Pharmaceuticals Initiates Phase II Trial of Novel IV and Oral Anti-Platelet Drug in Non-Urgent Percutaneous Coronary Intervention
5. Novel VELCADE(R) (Bortezomib) for Injection Based Four-Drug Combination Was Well Tolerated In Previously Untreated Multiple Myeloma Patients
6. Novel Therapeutic Approaches May Transform Treatment and Improve Patient Outcomes in Several Platelet Disorders
7. VentiRx Pharmaceuticals Commences Phase I Clinical Trial of VTX-2337, a Novel TLR8 Agonist for the Treatment of Oncology
8. Sequoia Pharmaceuticals Presents In Vitro and First-in-Human Data Supporting Further Development of SPI-256, a Novel Investigational Protease Inhibitor
9. Addrenex Pharmaceuticals Initiates Phase 2 Trial on Its Novel Hypertension Drug, ADX415
10. Millennium Presents New Data on Investigational Drugs for Novel Cancer Targets at EORTC-NCI-AACR Symposium
11. CeNeRx BioPharma Initiates Phase II Clinical Trial of Its Novel Antidepressant Agent Tyrima(TM)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...e-FirstCall/--QuestDiagnosticsIncorporated(NYSE: D...informationandservices,announcedthatitisscheduledt...nceinNewYorkCity.ThepresentationisscheduledforWedn...uringtheconference,thecompanywillreaffirmits2009gu...ometoexceed18%ofrevenues,anddilutedearningspershar...
(Date:11/24/2009)...rstCall/--AnadysPharmaceuticals,Inc.(Nasdaq: ANDS ...erJaffrayHealthcareConferenceonTuesday,December1,2...heldatTheNewYorkPalaceHotel.SteveWorland,Ph.D.,Pre...anoverviewofAnadysanditsclinicaldevelopmentprogram...illbesimultaneouslywebcastandcanbeaccessedontheInv...
(Date:11/24/2009).../--Inadditiontofamily,friendsandhealth,cancersurvi...nksgivinggratitudelist. ,, "Theyheardthefactsan...onday,sverdictstotaling$103millionindamagesagainst...omennationwidewhohavesuedWyethandPfizerpharmaceuti...pro.Wisneskiandtheothervictimsofhormonetherapyhave...
Breaking Medicine Technology:Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2Maryland Woman Thankful for Wyeth Verdicts 2The Jones Center for Diabetes 26amp 3B Endocrine Wellness Selects Retasure to Enhance Diabetes Care 54138 1The Jones Center for Diabetes 26amp 3B Endocrine Wellness Selects Retasure to Enhance Diabetes Care 54138 2ZyDoc Medical Transcription Completes Acquisition of Administrative Advantage 54135 1ZyDoc Medical Transcription Completes Acquisition of Administrative Advantage 54135 2ZyDoc Medical Transcription Completes Acquisition of Administrative Advantage 54135 3ZyDoc Medical Transcription Completes Acquisition of Administrative Advantage 54135 4ZyDoc Medical Transcription Completes Acquisition of Administrative Advantage 54135 5Astellas Seeks Rigorous Testing and Safety Related Labeling for Anti Rejection Medications 54132 1Astellas Seeks Rigorous Testing and Safety Related Labeling for Anti Rejection Medications 54132 2Astellas Seeks Rigorous Testing and Safety Related Labeling for Anti Rejection Medications 54132 3Astellas Seeks Rigorous Testing and Safety Related Labeling for Anti Rejection Medications 54132 4Astellas Seeks Rigorous Testing and Safety Related Labeling for Anti Rejection Medications 54132 5
..., Colo., Oct. 3 Tapestry,Pharmaceuticals, Inc. (N...ed,a Phase 2 open- label, multi-center study of TP... This is the second Phase 2 trial exploring the,ac...t Phase 2 trial began,earlier this year in advance...available taxanes are not approved for pancreatic ...
...Dose of Estradiol Shown to Be Safe and Effective f...n, WEST PALM BEACH, Fla., Oct. 3 A study present...merican Menopause Society (NAMS),revealed that Div... the,frequency and severity of moderate to severe ...data presented at the meeting found that Divigel(R...
Other Medicine Technology:Tapestry Initiates Phase 2 Trial of TPI 287 for the Treatment of Advanced Pancreatic Cancer 2Tapestry Initiates Phase 2 Trial of TPI 287 for the Treatment of Advanced Pancreatic Cancer 3Tapestry Initiates Phase 2 Trial of TPI 287 for the Treatment of Advanced Pancreatic Cancer 4Tapestry Initiates Phase 2 Trial of TPI 287 for the Treatment of Advanced Pancreatic Cancer 5New Data Reveal Topical Divigel(R) (estradiol gel) 0.1% Significantly Reduces Frequency and Severity of Hot Flashes 2
(Date:11/25/2009)...,Nov.25/PRNewswire/--TheBartleHallConventionCenter...iconDec.9-10,whenKansasCityhoststhelatestinaseries...sfreecliniceventhasthepotentialtobethebiggestoneye...dbeheldonweekdaysinsteadofoveraweekend,"SheriWood,...dpresidentoftheNationalAssociationofFreeClinics(NA...
(Date:11/25/2009)...if.,Nov.25/PRNewswire-FirstCall/-- OnyxPharmaceut...anywillhosttwoinvestoreventsinDecember: ,, AS...0a.m.ET ,, Principalinvestigatorswilldiscussd...d/orrefractorymultiplemyeloma,asfeaturedatthe51stA...ositioninNewOrleans,LA.Theteleconferencewillbegina...
(Date:11/25/2009)...ARY,Nov.25/PRNewswire/-SentinelleMedicalInc.,alead...sandsoftwareandCalgaryScientificInc.,aleadingprovi...ebversionofAegis(TM)Breast4DAdvancedVisualizations...ulyzero-footprintWebclientbasedmedicalimagingoffer...ormallowsforzero-footprintaccess-requiringnosoftwa...
(Date:11/25/2009).../PRNewswire/-SentinelleMedicalInc.,aleadingmanufac...arelaunchesasuiteofnewleadingedgeclinicalapplicati...hisyear,sRadiologicalSocietyofNorthAmerica(RSNA)an...allA).Theapplicationsleveragetheuniquehighqualityi...oilsandsupportmultipleimagingmodalitiesformulti-pa...
(Date:11/25/2009)...f.,Nov.25/PRNewswire/--Thanksgivingmealswillbedeli...terLongBeachareathankstoFaithInAction/VolunteerAct...AH),adivisionofSCANHealthPlan.Formorethan17yearsth...deliverwarmThanksgivingmealstoseniorsinneedinLongB...ndsurroundingcities. ,, "Ourwarmholidaymealsare...
Breaking Medicine News(10 mins):Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2
...s anti-cancer drug `Tarceva' (erlotinib), which `p.../, suffering from lung cancer. The Managing D...taken once a day and has the potential to treat ma...ne prior chemotherapy regiment. Dr. Telang al...
... ?6.2bn upgrade of the NHS IT system has to be th...ter Weekly magazine said that the group of academi...he government responded by saying that the plan wa... 2012. However the experts say that this means tha...
... ahs been found that survival rates following the ...-fold when emergency medical// personnel used a ne...na Sarver Heart Center. Cardiocerebral Resuscita... Kellum, MD, leading author of the study report, "...
...ssuming the role of a doctor but pretty bad at adm... Queensland University// of Technology has reveale...their children an incorrect dose of medication, al... risen from 12% in 1987 to 33 per cent in 2002.It ...
... Russell and her six-year-old daughter, Megan. Now...port// which details widespread failures by the au...m his point of view he says that the disclosure of...nother of Mrs Russell's daughters, Josie, who surv...
...esday gave an optimistic report about the world’s ...rizon// included worries about the impact of a pot...utbreak in humans could cause high absenteeism in ... international finance systems, the Global Financi...
Other Medicine News:Health News:Paramedics save more lives following unconventional rules 2Health News:IMF considers Bird Flu to be a Dark Cloud 2
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
Medicine Products: